000 01613 a2200385 4500
005 20250516014748.0
264 0 _c20110328
008 201103s 0 0 eng d
022 _a1537-6591
024 7 _a10.1093/cid/ciq042
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeggs, Karl S
245 0 0 _aDirectly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.
_h[electronic resource]
260 _bClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_cJan 2011
300 _a49-57 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCytomegalovirus
_ximmunology
650 0 4 _aCytomegalovirus Infections
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xmethods
650 0 4 _aInterferon-gamma
_xmetabolism
650 0 4 _aStem Cell Transplantation
650 0 4 _aT-Lymphocytes
_ximmunology
650 0 4 _aTreatment Outcome
700 1 _aThomson, Kirsty
700 1 _aSamuel, Edward
700 1 _aDyer, Gemma
700 1 _aArmoogum, Julie
700 1 _aChakraverty, Ronjon
700 1 _aPang, Kwok
700 1 _aMackinnon, Stephen
700 1 _aLowdell, Mark W
773 0 _tClinical infectious diseases : an official publication of the Infectious Diseases Society of America
_gvol. 52
_gno. 1
_gp. 49-57
856 4 0 _uhttps://doi.org/10.1093/cid/ciq042
_zAvailable from publisher's website
999 _c20438781
_d20438781